No Data
No Data
Bright Minds Biosciences Brief: Announcing "Positive" QEEG (Quantitative Electroencephalogram) Data From Its First-in-Human Phase 1 Study of Lead Compound, BMB-101
06:58 AM EDT, 08/08/2023 (MT Newswires) -- Bright Minds Biosciences Brief: Announcing "Positive" qEEG (Quantitative Electroencephalogram) Data from its First-in-Human Phase 1 Study of Lead Compound, B
Bright Minds Biosciences Brief: Announced "Positive" Topline Data for Its First-in-Human Phase 1 Study of Lead Compound, BMB-101
06:54 AM EDT, 07/20/2023 (MT Newswires) -- Bright Minds Biosciences Brief: Announced "Positive" Topline Data for its First-in-Human Phase 1 Study of Lead Compound, BMB-101
Thinking About Buying Stock in Mind Medicine (MindMed), OPKO Health, Grange Resources, Hyzon...
CSE Bulletin: Consolidation - Bright Minds Biosciences Inc. (DRUG)
Toronto, Ontario--(Newsfile Corp. - Le 12 juillet/July 2023) - Bright Minds Biosciences Inc. has announced a consolidation of its issued and outstanding common shares on the basis of one (1) post-cons
Bright Minds Goes For 5:1 Shares Consolidation, Hopes To Regain NASDAQ Compliance
Bright Minds Biosciences Inc. (NASDAQ:DRUG) is going for a consolidation of its common shares on a five-to-one basis, a plan approved by the company's board of directors in June.
Bright Minds Announces Effective Date of Share Consolidation